148
Views
15
CrossRef citations to date
0
Altmetric
Original

Gestational age at initiation of 17-hydroxyprogesterone caproate (17P) and recurrent preterm delivery

, MD, MPH, , , , , , , MD, MPH, , , , & show all
Pages 249-252 | Received 01 Sep 2006, Accepted 02 Nov 2006, Published online: 07 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Julia Timofeev, Maisa Feghali, Annelee Boyle, Niki Istwan, Debbie Rhea & Rita W. Driggers. (2013) Rates of recurrent preterm birth by maternal body habitus in women receiving 17α-hydroxyprogesterone caproate. The Journal of Maternal-Fetal & Neonatal Medicine 26:9, pages 881-884.
Read now
GS Jayasooriya & RF Lamont. (2009) The use of progesterone and other progestational agents to prevent spontaneous preterm labour and preterm birth. Expert Opinion on Pharmacotherapy 10:6, pages 1007-1016.
Read now

Articles from other publishers (13)

Ahizechukwu C. Eke, Jeanne Sheffield & Ernest M. Graham. (2019) Adjuvant 17-hydroxyprogesterone caproate in women with history-indicated cerclage: A systematic review and meta-analysis. Acta Obstetricia et Gynecologica Scandinavica 98:2, pages 139-153.
Crossref
Matthew K. Hoffman. (2018) Changing Preterm Birth in Delaware. Delaware Journal of Public Health 4:3, pages 18-21.
Crossref
Priya Batra, Ashley A. Hernandez Gray & Jennifer E. Moore. (2017) Variation in Coverage for Progesterone to Prevent Preterm Birth: A Survey of Medicaid Managed Care Organizations. Women's Health Issues 27:5, pages 573-578.
Crossref
Angela Ning, Catherine J. Vladutiu, Sarah K. Dotters-Katz, William H. Goodnight & Tracy A. Manuck. (2017) Gestational age at initiation of 17-alpha hydroxyprogesterone caproate and recurrent preterm birth. American Journal of Obstetrics and Gynecology 217:3, pages 371.e1-371.e7.
Crossref
Steve N. Caritis, Maisa N. Feghali, William A. Grobman & Dwight J. Rouse. (2016) What we have learned about the role of 17-alpha-hydroxyprogesterone caproate in the prevention of preterm birth. Seminars in Perinatology 40:5, pages 273-280.
Crossref
Norbert Winer, Florence Bretelle, Marie-Victoire Senat, Caroline Bohec, Philippe Deruelle, Frank Perrotin, Laure Connan, Christophe Vayssière, Bruno Langer, Marianne Capelle, Shohreh Azimi, Raphael Porcher & Patrick Rozenberg. (2015) 17 alpha-hydroxyprogesterone caproate does not prolong pregnancy or reduce the rate of preterm birth in women at high risk for preterm delivery and a short cervix: a randomized controlled trial. American Journal of Obstetrics and Gynecology 212:4, pages 485.e1-485.e10.
Crossref
Digna R. Velez Edwards, Frances E. Likis, Jeffrey C. Andrews, Alison L. Woodworth, Rebecca N. Jerome, Christopher J. Fonnesbeck, J. Nikki McKoy & Katherine E. Hartmann. (2013) Progestogens for preterm birth prevention: a systematic review and meta-analysis by drug route. Archives of Gynecology and Obstetrics 287:6, pages 1059-1066.
Crossref
. (2012) Progesterone and preterm birth prevention: translating clinical trials data into clinical practice. American Journal of Obstetrics and Gynecology 206:5, pages 376-386.
Crossref
Carla E. Ransom & Amy P. Murtha. (2012) Progesterone for Preterm Birth Prevention. Obstetrics and Gynecology Clinics of North America 39:1, pages 1-16.
Crossref
Tracy A. Manuck, Erick Henry, Jonathan Gibson, Michael W. Varner, T. Flint Porter, G. Marc Jackson & M. Sean Esplin. (2011) Pregnancy outcomes in a recurrent preterm birth prevention clinic. American Journal of Obstetrics and Gynecology 204:4, pages 320.e1-320.e6.
Crossref
Victor H. González-Quintero, Lesley de la Torre, Debbie J. Rhea, Carmen M. Tudela, Enrique Vazquez-Vera, Cheryl Desch & Niki B. Istwan. (2010) Impact of prior gestational age at preterm delivery on effectiveness of 17-alpha-hydroxyprogesterone caproate in practice. American Journal of Obstetrics and Gynecology 203:3, pages 257.e1-257.e5.
Crossref
Helen Y. How, John R. Barton, Niki B. Istwan, Debbie J. Rhea & Gary J. Stanziano. (2007) Prophylaxis with 17 alpha-hydroxyprogesterone caproate for prevention of recurrent preterm delivery: does gestational age at initiation of treatment matter?. American Journal of Obstetrics and Gynecology 197:3, pages 260.e1-260.e4.
Crossref
Charles Rittenberg, Scott Sullivan, Niki Istwan, Debbie Rhea, Gary Stanziano & Roger Newman. (2007) Clinical characteristics of women prescribed 17 alpha-hydroxyprogesterone caproate in the community setting. American Journal of Obstetrics and Gynecology 197:3, pages 262.e1-262.e4.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.